Roquefort Therapeutics PLC - UK-based biotech company - Forms scientific advisory board to provide scientific guidance on strategy, as the company moves towards key pre-clinical milestones and clinical trials. Says SAB will initially comprise of Jo Martin, Trevor Jones and Armand Keating. Aims to use their drug development expertise to complete pre-clinical development to reach valuation milestones for licensing transactions or sale of a clinical programme.

Current stock price: 7.30 pence, down 12%

12-month change: down 20%

Copyright 2023 Alliance News Ltd. All Rights Reserved